| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RNA, 7SL, cytoplasmic 263, pseudogene | 0.496 | 0.808 |
|
disease | 0.100 | None | 0.893 | 28 | 0 | 2011 | 2019 | |||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2011 | 2017 | |||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2011 | 2017 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2008 | 2017 | |||||||||
|
Pulmonary disease, chronic obstructive, severe early-onset | 0.456 | 0.885 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2017 | 2018 | |||||||||
|
glucosylceramidase beta pseudogene 1 | 0.623 | 0.538 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2004 | 2017 | |||||||||
|
microRNA 144 | 0.500 | 0.769 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2019 | |||||||||
|
thoracoabdominal syndrome | 0.560 | 0.808 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2012 | 2018 | |||||||||
|
endogenous retrovirus group K member 20 | 0.533 | 0.692 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1991 | 1999 | |||||||||
|
Restless legs syndrome, susceptibility to | 0.705 | 0.423 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | |||||||||
|
endogenous retrovirus group W member 1, envelope | 0.505 | 0.692 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1991 | 1999 | |||||||||
|
BPI fold containing family A member 4, pseudogene | 0.711 | 0.654 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1984 | 2016 | |||||||||
|
interferon alpha 2 | 0.442 | 0.885 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 1991 | 2012 | |||||||||
|
microRNA 146a | 0.398 | 0.885 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2018 | |||||||||
|
endogenous retrovirus group K member 6, envelope | 0.521 | 0.808 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1991 | 1999 | |||||||||
|
loss of heterozygosity, 19, chromosomal region 1 | 0.569 | 0.808 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | |||||||||
|
transient erythroblastopenia of childhood | 0.659 | 0.577 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1997 | 1997 | |||||||||
|
chromosome 20 open reading frame 181 | 0.479 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
WASH complex subunit 1 | 0.780 | 0.308 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
Cholangitis, primary sclerosing | 0.603 | 0.731 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
interferon lambda 4 (gene/pseudogene) | 0.670 | 0.577 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2020 | 2020 | |||||||||
|
long intergenic non-protein coding RNA 1152 | 0.729 | 0.231 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1990 | 1990 | |||||||||
|
immunoglobulin heavy variable 4-38-2-like | 0.514 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | |||||||||
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 | 0.527 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 |